Qing Mao
About
Qing Mao is a scholar working on Molecular Biology, Nephrology and Surgery.
According to data from OpenAlex, Qing Mao has authored 33 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Nephrology and 8 papers in Surgery. Recurrent topics in Qing Mao's work include Gout, Hyperuricemia, Uric Acid (9 papers), Eosinophilic Disorders and Syndromes (6 papers) and Vascular Malformations and Hemangiomas (3 papers). Qing Mao is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (9 papers), Eosinophilic Disorders and Syndromes (6 papers) and Vascular Malformations and Hemangiomas (3 papers). Qing Mao collaborates with scholars based in China. Qing Mao's co-authors include Bing Zhang, Shaojie Wang, Zhiyuan Zhang, Weiliu Qiu, Xindong Fan, Yulin Duan, Yuwei Yang, Feng Yao, Shaojie Wang and Jun Gao and has published in prestigious journals such as Journal of Medicinal Chemistry, Green Chemistry and Annals of Oncology.
In The Last Decade
Qing Mao
30 papers receiving 407 citations
Peers
Qing Mao
Yoichiro Takami Japan
Jin‐Ling Huo China
P.L. Capecchi Italy
Andrea Thueringer Austria
Setsuro Fujii Japan
Yuan Zhuang China
Tomoji Kawabata Japan
Jie-wei Luo China
D. Bucher Denmark
Citations per year, relative to Qing Mao Qing Mao (= 1×)
peers
Yoichiro Takami
Countries citing papers authored by Qing Mao
Since
Specialization
Citations
This map shows the geographic impact of Qing Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Mao more than expected).
Fields of papers citing papers by Qing Mao
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Qing Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Mao. The network helps show where Qing Mao may publish in the future.
Co-authorship network of co-authors of Qing Mao
This figure shows the co-authorship network connecting the top 25 collaborators of Qing Mao. A scholar is included among the top collaborators of Qing Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Mao. Qing Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sun, Ming, Chang Liu, Dan Liu, et al.. (2025). Scaffold hopping-based structural modification of tranilast led to the identification of HNW005 as a promising NLRP3 inflammasome and URAT1 dual inhibitor for the treatment of gouty arthritis. European Journal of Medicinal Chemistry. 292. 117644–117644.
2.
Han, Yuhan, Yufei Ma, Weiji Weng, et al.. (2025). Intraoperative application of an antioxidant nanoparticle-hydrogel targeting microglia regulates neuroinflammation in traumatic brain injury. Journal of Nanobiotechnology. 23(1). 599–599.
3.
Dai, Cong, Yueguang Liu, Jia Yin, et al.. (2024). 460P Exploring the efficacy and optimal timing of tumor treating fields in newly diagnosed glioblastoma: A real-world study. Annals of Oncology. 35. S413–S414.
4.
Sun, Ming, Jun Gao, Bing Zhang, et al.. (2023). Identification of 5-[5-cyano-1-(pyridin-2-ylmethyl)-1H-indole-3-carboxamido] thiazole-4-carboxylic acid as a promising dual inhibitor of urate transporter 1 and xanthine oxidase. European Journal of Medicinal Chemistry. 257. 115532–115532.
5.
Zhao, Jiaxing, Qing Mao, Peng Zhang, et al.. (2022). Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5-ASA–PABA–MAC and 5-ASA–PABA–Diamine for the Treatment of Ulcerative Colitis. Journal of Medicinal Chemistry. 65(6). 4926–4948.
6.
Yao, Feng, Bing Zhang, Peng Zhang, et al.. (2022). Scaffold hopping of celastrol provides derivatives containing pepper ring, pyrazine and oxazole substructures as potent autophagy inducers against breast cancer cell line MCF-7. European Journal of Medicinal Chemistry. 234. 114254–114254.
7.
Zhang, Bing, Yulin Duan, Yuwei Yang, et al.. (2021). Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors. European Journal of Medicinal Chemistry. 227. 113928–113928.
8.
Lei, Yu, Yan Zhang, Yulin Duan, et al.. (2021). Design, synthesis and biological evaluation of novel FXIa inhibitors with 2-phenyl-1H-imidazole-5-carboxamide moiety as P1 fragment. European Journal of Medicinal Chemistry. 220. 113437–113437.
9.
Sun, Ming, Jiaxing Zhao, Qing Mao, et al.. (2021). Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site. Bioorganic & Medicinal Chemistry. 38. 116117–116117.
10.
Zhao, Jiaxing, Qing Mao, Bing Zhang, et al.. (2021). Intramolecular hydrogen bond interruption and scaffold hopping of TMC-5 led to 2-(4-alkoxy-3-cyanophenyl)pyrimidine-4/5-carboxylic acids and 6-(4-alkoxy-3-cyanophenyl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones as potent pyrimidine-based xanthine oxidase inhibitors. European Journal of Medicinal Chemistry. 229. 114086–114086.
11.
Liu, Xuegui, et al.. (2020). Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors. European Journal of Medicinal Chemistry. 190. 112077–112077.
12.
Lei, Yu, Dan Liu, Jian Zhao, et al.. (2020). Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y1 and P2Y12 as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor. Journal of Medicinal Chemistry. 63(24). 15752–15772.
13.
Zhang, Bing, et al.. (2019). Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives. European Journal of Medicinal Chemistry. 181. 111559–111559.
14.
Gao, Jun, Zhaofeng Zhang, Bing Zhang, et al.. (2019). Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation. Bioorganic Chemistry. 95. 103564–103564.
15.
Mao, Qing, et al.. (2019). Design, synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenyl-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives as novel xanthine oxidase inhibitors. European Journal of Medicinal Chemistry. 181. 111558–111558.
16.
Wang, Xiang, Xuhui Hui, Jianping Liu, & Qing Mao. (2012). Radiation-induced cavernous malformation at the site of arteriovenous malformation following gamma knife radiosurgery: Case report. Clinical Neurology and Neurosurgery. 114(9). 1287–1289.
17.
Fan, Xindong, Zhiyuan Zhang, Chenping Zhang, et al.. (2002). Direct-puncture embolization of intraosseous arteriovenous malformation of jaws. Journal of Oral and Maxillofacial Surgery. 60(8). 890–896.
18.
Fan, Xindong, Weiliu Qiu, Zhiyuan Zhang, & Qing Mao. (2002). Comparative study of clinical manifestation, plain-film radiography, and computed tomographic scan in arteriovenous malformations of the jaws. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 94(4). 503–509.
19.
Fan, Xin & Qing Mao. (2002). Life-threatening oral haemorrhage of a pseudoaneurysm after raising of a fractured zygoma. British Journal of Oral and Maxillofacial Surgery. 40(6). 508–509.
20.
Mao, Qing & Beverly L. Davidson. (2001). Development expression of CLN3 in the mouse nervous system. The Society for Neuroscience Abstracts. 27(1). 55.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yoichiro Takami Breakdown of academic impact, for papers by Jin‐Ling Huo Breakdown of academic impact, for papers by P.L. Capecchi Breakdown of academic impact, for papers by Andrea Thueringer Breakdown of academic impact, for papers by Setsuro Fujii Breakdown of academic impact, for papers by Yuan Zhuang Breakdown of academic impact, for papers by Tomoji Kawabata Breakdown of academic impact, for papers by Jie-wei Luo Breakdown of academic impact, for papers by D. Bucher